Companies will collaborate on an AI-powered care improvement solution for patients with high-risk COPD Viz.ai, the leader in AI-powered disease detection and intelligent care coordination,
Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicine FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization for biologics,
Regeneron’s ongoing and planned investments in New York and North Carolina infrastructure and manufacturing expected to total more than $7 billion Regeneron Pharmaceuticals, Inc. announced
Fuel up with free Health Tech Insights
